May
03
2024
In a first-in-human study, a new class of transcatheter heart valve demonstrated good safety and restored aortic blood flow to levels similar to a healthy aortic valve at 1 year, a speaker reported.
The results of a prospective, single-center study evaluating the safety and feasibility of a biomimetic valve (DurAVR, Anteris) in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement were presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.
The investigational device is a balloon-expandable, single-piece, native-shaped
Read More
Healio.com CARDIOLOGY •
Heart Disease for Doctors •
